GHK-Cu
$59.99
In stockGHK-Cu is a copper(II)-binding complex of the tripeptide glycyl-L-histidyl-L-lysine studied in extracellular-matrix biology, copper transport, cellular signaling, and tissue-remodeling models.
| SKU | RC-ST-GHKCU-50MG |
|---|---|
| Manufacturer | Strandix Peptides |
| Form | Lyophilized Powder |
| Strength | 50 mg |
| Size | 3 mL Vial |
| Reported Result | Supplier spec pending verification |
| Stock | In stock |
| Documentation Status | Pending Final COA |
GHK-Cu is formed when the tripeptide glycyl-L-histidyl-L-lysine coordinates copper(II). GHK was originally identified in human plasma and has been studied as a small copper-binding peptide with effects in experimental models involving extracellular-matrix turnover, fibroblast activity, inflammatory signaling, angiogenic responses, and gene expression. The copper complex and the uncomplexed GHK peptide are related but chemically distinct materials. Product identity therefore depends on copper stoichiometry, peptide sequence, counterions, hydration, and purity.
Storage and handling: Follow the manufacturer label and matching batch documentation.
Third-party testing status.
| Batch / Lot | Reported Result | Tested | Partner | Status | Document |
|---|---|---|---|---|---|
| N/A | Supplier spec pending verification | Pending | Pending | Pending Final COA | Pending Final COA |